SCHEMBL3908426

SCHEMBL3908426

COC(=O)C1=C(Nc2ccc(S(=O)(=O)O)cc2)CC(C(=O)OC)=C(Nc2ccc(S(=O)(=O)O)cc2)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.41
▸ SNCA P37840 2/20 0.40
▸ GLA P06280 1/20 0.38
▸ PTPRA P18433 1/20 0.37
▸ PTPRB P23467 1/20 0.37
▸ TIMP3 P35625 1/20 0.36
▸ TSHR P16473 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ CA12 O43570 2/20 0.36
▸ CA1 P00915 2/20 0.36
▸ CA2 P00918 2/20 0.36
▸ CA9 Q16790 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ CA14 Q9ULX7 1/20 0.36
▸ TUBB4A P04350 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3908437 0.82 ALDH1A1 (0.41) MAPTTSHRALDH1A1GAASMN1; SMN2
SCHEMBL1415828 0.81 TDP1 (0.48) MAPTTSHRALDH1A1GAAHTT
SCHEMBL1415617 0.80 SLC6A3 (0.49) MAPTALDH1A1GAAPKMHPGD
SCHEMBL1415465 0.80 MEN1 (0.49) MAPTALDH1A1HTTSMN1; SMN2PKM
SCHEMBL1415808 0.80 HTT (0.54) MAPTTSHRALDH1A1GAAALOX15
SCHEMBL3909905 0.79 MAPT (0.53) MAPTTSHRALDH1A1GAAALOX15
SCHEMBL3902803 0.77 MAPT (0.45) MAPTTSHRALDH1A1GAAHTT
SCHEMBL3905197 0.77 SLC6A3 (0.52) MAPTTSHRALOX15SMN1; SMN2HPGD
SCHEMBL12392802 0.76 ACHE (0.43) MAPTTSHRALDH1A1GAAHTT
SCHEMBL3908430 0.75 ACHE (0.33) MAPTSNCAPKMCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0632106-B2 Process for the production of 2,5-di(arylamino)-3,6- dihydroterephthalic acid dialkyl ester, and process for the production of quinacridone from said ester as intermediate TOYO INK MFG CO (JP) 2009-02-25 — — EP disclosed
EP-0632106-B1 Process for the production of 2,5-di(arylamino)-3,6- dihydroterephthalic acid dialkyl ester, and process for the production of quinacridone from said ester as intermediate TOYO INK MFG CO (JP) 2001-08-22 — — EP disclosed
US-5817817-A Process for the production of 2,5-di(arylamino)-3,6-dihydroterephthalic acid dialkyl ester, and process for the production of quinacridone from said ester as intermediate TOYO INK MANUFACTURING CO., LTD. (JP) 1998-10-06 — — US disclosed
US-5659036-A Process for the production of 2,5-di(arylamino)-3,6-dihydroterephthalic acid dialkyl ester, and process for the production of quinacridone from said ester as intermediate TOYO INK MANUFACTURING CO., LTD. (JP) 1997-08-19 — — US disclosed
EP-0632106-A1 Process for the production of 2,5-di(arylamino)-3,6- dihydroterephthalic acid dialkyl ester, and process for the production of quinacridone from said ester as intermediate TOYO INK MANUFACTURING CO., LTD. (JP) 1995-01-04 — — EP disclosed
Send feedback